Department of Anesthesia, Southwest Hospital, The Third Military Medical University, Chongqing 400038, China.
Biochem Biophys Res Commun. 2012 Feb 24;418(4):598-602. doi: 10.1016/j.bbrc.2012.01.034. Epub 2012 Jan 24.
Our previous work has demonstrated that the cellular phenotype changes of human pulmonary artery smooth muscle cells (PASMCs) play an important role during pulmonary vascular remodelling. However, little is known about the role of PASMCs phenotype modulation in the course of hypoxia-induced migration and its behind molecular mechanisms. In this study, we have shown that cGMP-dependent protein kinase (PKG) Iα transfection significantly attenuated the hypoxia-induced down-regulation of the expressions of SM-α-actin, MHC and calponin. Hypoxia-induced PASMC migration was also suppressed by PKGIα overexpression. Furthermore, this overexpression attenuated ANX A1 upregulation under hypoxic conditions. All those effects were reversed by a PKG inhibitor KT5823. Our data indicate that manipulating upstream entity e.g., PKGIa, may have a potential therapeutic value to prevent hypoxia-associated pulmonary arterial remodeling for pulmonary hypertension development.
我们之前的工作表明,人肺动脉平滑肌细胞(PASMCs)的细胞表型变化在肺血管重构过程中起着重要作用。然而,对于 PASMCs 表型调节在缺氧诱导的迁移过程中的作用及其背后的分子机制知之甚少。在这项研究中,我们表明,cGMP 依赖性蛋白激酶(PKG)Iα 转染显著减弱了缺氧诱导的 SM-α-肌动蛋白、MHC 和钙调蛋白表达的下调。PKGIα 的过表达也抑制了缺氧诱导的 PASMC 迁移。此外,这种过表达减弱了缺氧条件下 ANX A1 的上调。所有这些作用都被 PKG 抑制剂 KT5823 逆转。我们的数据表明,操纵上游实体(例如 PKGIa)可能具有潜在的治疗价值,可用于预防与缺氧相关的肺动脉重塑,从而防止肺动脉高压的发展。